These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 29419819)
1. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers. Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype. Enns GM; Ammous Z; Himes RW; Nogueira J; Palle S; Sullivan M; Ramirez C Mol Genet Metab; 2021 Nov; 134(3):217-222. PubMed ID: 34625341 [TBL] [Abstract][Full Text] [Related]
3. A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum. Lee J; Yergeau C; Kawai K; Braverman N; Géléoc GSG Ear Hear; 2022; 43(2):582-591. PubMed ID: 34534157 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders. Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder. Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines. Braverman NE; Raymond GV; Rizzo WB; Moser AB; Wilkinson ME; Stone EM; Steinberg SJ; Wangler MF; Rush ET; Hacia JG; Bose M Mol Genet Metab; 2016 Mar; 117(3):313-21. PubMed ID: 26750748 [TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities. Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495 [TBL] [Abstract][Full Text] [Related]
8. Atypical PEX16 peroxisome biogenesis disorder with mild biochemical disruptions and long survival. Zaabi NA; Kendi A; Al-Jasmi F; Takashima S; Shimozawa N; Al-Dirbashi OY Brain Dev; 2019 Jan; 41(1):57-65. PubMed ID: 30078639 [TBL] [Abstract][Full Text] [Related]
9. Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation. Cheillan D Adv Exp Med Biol; 2020; 1299():71-80. PubMed ID: 33417208 [TBL] [Abstract][Full Text] [Related]
10. Drosophila Models Uncover Substrate Channeling Effects on Phospholipids and Sphingolipids in Peroxisomal Biogenesis Disorders. Wangler MF; Chao YH; Roth M; Welti R; McNew JA bioRxiv; 2024 Apr; ():. PubMed ID: 38746221 [TBL] [Abstract][Full Text] [Related]
11. Low bone mineral density is a common feature of Zellweger spectrum disorders. Rush ET; Goodwin JL; Braverman NE; Rizzo WB Mol Genet Metab; 2016 Jan; 117(1):33-7. PubMed ID: 26643206 [TBL] [Abstract][Full Text] [Related]
12. Hypomorphic mutation of PEX3 with peroxisomal mosaicism reveals the oscillating nature of peroxisome biogenesis coupled with differential metabolic activities. Takashima S; Fujita H; Toyoshi K; Ohba A; Hirata Y; Shimozawa N; Oh-Hashi K Mol Genet Metab; 2022; 137(1-2):68-80. PubMed ID: 35932552 [TBL] [Abstract][Full Text] [Related]
13. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder. Hiebler S; Masuda T; Hacia JG; Moser AB; Faust PL; Liu A; Chowdhury N; Huang N; Lauer A; Bennett J; Watkins PA; Zack DJ; Braverman NE; Raymond GV; Steinberg SJ Mol Genet Metab; 2014 Apr; 111(4):522-532. PubMed ID: 24503136 [TBL] [Abstract][Full Text] [Related]
14. Development and validation of a severity scoring system for Zellweger spectrum disorders. Klouwer FCC; Meester-Delver A; Vaz FM; Waterham HR; Hennekam RCM; Poll-The BT Clin Genet; 2018 Mar; 93(3):613-621. PubMed ID: 28857144 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders. Yik WY; Steinberg SJ; Moser AB; Moser HW; Hacia JG Hum Mutat; 2009 Mar; 30(3):E467-80. PubMed ID: 19105186 [TBL] [Abstract][Full Text] [Related]